Total Payments
$112,514
2024 Payments
$13,468
Companies
24
Transactions
137
Medicare Patients
1,028
Medicare Billing
$210,087
Payment Breakdown by Category
Consulting$87,467 (77.7%)
Other$11,620 (10.3%)
Travel$6,992 (6.2%)
Food & Beverage$6,403 (5.7%)
Education$31.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $87,467 | 27 | 77.7% |
| Travel and Lodging | $6,992 | 27 | 6.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,720 | 3 | 6.0% |
| Food and Beverage | $6,403 | 77 | 5.7% |
| Honoraria | $4,900 | 2 | 4.4% |
| Education | $31.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kyowa Kirin, Inc. | $34,868 | 20 | $0 (2024) |
| ADC Therapeutics America, Inc. | $24,061 | 16 | $0 (2024) |
| Acrotech Biopharma Inc. | $12,099 | 18 | $0 (2024) |
| Seagen Inc. | $8,928 | 12 | $0 (2023) |
| Seattle Genetics, Inc. | $6,541 | 19 | $0 (2019) |
| Genentech, Inc. | $6,260 | 6 | $0 (2023) |
| Gilead Sciences, Inc. | $4,750 | 9 | $0 (2020) |
| Verastem, Inc. | $4,184 | 3 | $0 (2020) |
| Aurobindo Pharma USA, Inc. | $2,320 | 5 | $0 (2020) |
| Daiichi Sankyo Inc. | $2,031 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,468 | 21 | ADC Therapeutics America, Inc. ($9,199) |
| 2023 | $6,339 | 9 | Genentech, Inc. ($6,260) |
| 2022 | $37,155 | 33 | ADC Therapeutics America, Inc. ($14,862) |
| 2021 | $10,391 | 4 | Kyowa Kirin, Inc. ($7,860) |
| 2020 | $12,974 | 9 | Kyowa Kirin, Inc. ($7,860) |
| 2019 | $25,745 | 31 | Kyowa Kirin, Inc. ($13,690) |
| 2018 | $1,828 | 11 | Bayer HealthCare Pharmaceuticals Inc. ($800.00) |
| 2017 | $4,614 | 19 | Seattle Genetics, Inc. ($3,682) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $51.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $16.00 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $45.35 | General |
| Category: Monoclonal Antibody | ||||||
| 12/08/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 10/25/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $496.95 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $149.24 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $60.38 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Travel and Lodging | In-kind items and services | $150.93 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Acrotech Biopharma Inc. | BELEODAQ (Drug) | Food and Beverage | In-kind items and services | $120.22 | General |
| Category: ONCOLOGY | ||||||
| 10/05/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $82.11 | General |
| 06/06/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $141.38 | General |
| Category: Monoclonal Antibody | ||||||
| 05/05/2024 | Incyte Corporation | JAKAFI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| Category: Hematology/Oncology | ||||||
| 04/26/2024 | ADC Therapeutics America, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,400.00 | General |
| 04/12/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $83.75 | General |
| 03/01/2024 | ADC Therapeutics America, Inc. | — | Travel and Lodging | Cash or cash equivalent | $299.79 | General |
| 03/01/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $62.50 | General |
| 03/01/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $52.17 | General |
| 03/01/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $43.99 | General |
| 03/01/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| 10/29/2023 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $19.11 | General |
| Category: Hematology/Oncology | ||||||
| 06/08/2023 | Genentech, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 06/08/2023 | Genentech, Inc. | — | Travel and Lodging | Cash or cash equivalent | $93.93 | General |
| 06/08/2023 | Genentech, Inc. | — | Food and Beverage | Cash or cash equivalent | $69.24 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 279 | 592 | $275,131 | $58,235 |
| 2022 | 5 | 268 | 583 | $268,328 | $52,703 |
| 2021 | 5 | 238 | 541 | $237,842 | $49,985 |
| 2020 | 5 | 243 | 615 | $248,972 | $49,164 |
Total Patients
1,028
Total Services
2,331
Medicare Billing
$210,087
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 267 | $110,004 | $25,685 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 81 | 158 | $90,376 | $17,710 | 19.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 74 | $28,712 | $5,596 | 19.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 33 | 33 | $23,760 | $4,531 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 16 | $9,152 | $1,853 | 20.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 28 | $8,395 | $1,836 | 21.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $4,732 | $1,023 | 21.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 62 | 259 | $106,708 | $21,580 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 65 | 139 | $79,508 | $15,469 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 53 | 90 | $34,920 | $6,527 | 18.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $21,600 | $4,115 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 18 | $10,296 | $2,014 | 19.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 29 | 30 | $8,700 | $1,723 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 17 | $6,596 | $1,275 | 19.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 77 | 165 | $84,744 | $18,744 | 22.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 45 | 191 | $78,692 | $15,987 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 68 | 136 | $47,372 | $9,577 | 20.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $22,104 | $4,679 | 21.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 16 | 17 | $4,930 | $998.58 | 20.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 80 | 339 | $139,668 | $28,761 | 20.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 62 | 131 | $57,582 | $10,991 | 19.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 55 | 98 | $30,532 | $5,500 | 18.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 20 | 20 | $13,360 | $2,310 | 17.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 26 | 27 | $7,830 | $1,601 | 20.5% |
About Dr. Bradley Haverkos, MD
Dr. Bradley Haverkos, MD is a Internal Medicine healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1679707319.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Haverkos, MD has received a total of $112,514 in payments from pharmaceutical and medical device companies, with $13,468 received in 2024. These payments were reported across 137 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($87,467).
As a Medicare-enrolled provider, Haverkos has provided services to 1,028 Medicare beneficiaries, totaling 2,331 services with total Medicare billing of $210,087. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hematology & Oncology
- Location Aurora, CO
- Active Since 05/10/2009
- Last Updated 06/23/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679707319
Products in Payments
- POTELIGEO (Drug) $26,572
- BELEODAQ (Drug) $12,099
- ADCETRIS (Biological) $11,783
- SANCUSO (Drug) $7,860
- Copiktra (Drug) $4,184
- SGN35 (Biological) $3,579
- Beleodaq (Drug) $1,950
- Polivy (Biological) $1,097
- XPOVIO (Drug) $1,070
- Folotyn (Drug) $829.72
- Aliqopa (Drug) $800.00
- LEMTRADA (Biological) $500.00
- Imbruvica (Drug) $246.87
- Poteligeo (Drug) $213.32
- RYDAPT (Drug) $121.86
- MOZOBIL (Drug) $121.23
- GAZYVA (Biological) $106.87
- Evomela (Drug) $33.19
- JAKAFI (Drug) $32.51
- Yescarta (Drug) $25.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Aurora
Dr. Payal Kohli, M.d, M.D
Internal Medicine — Payments: $1.2M
Internal Medicine $1.2M
Dr. Wendy Tzou, M.d, M.D
Internal Medicine — Payments: $339,300
Internal Medicine $339,300
Miss. Sapna Patel, Md, MD
Internal Medicine — Payments: $188,415
Internal Medicine $188,415
Viralkumar Shah, Md, MD
Internal Medicine — Payments: $178,835
Internal Medicine $178,835
Dr. Elena Shagisultanova, Md, Phd, MD, PHD
Internal Medicine — Payments: $171,856
Internal Medicine $171,856
Lohit Garg, Md, MD
Internal Medicine — Payments: $121,577
Internal Medicine $121,577